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Abstract
Hundreds of RNA-binding proteins (RBPs) control diverse aspects of post-transcriptional gene regulation. To identify novel
and unconventional RBPs, we probed high-density protein microarrays with fluorescently labeled RNA and selected 200
proteins that reproducibly interacted with different types of RNA from budding yeast Saccharomyces cerevisiae. Surprisingly,
more than half of these proteins represent previously known enzymes, many of them acting in metabolism, providing
opportunities to directly connect intermediary metabolism with posttranscriptional gene regulation. We mapped the RNA
targets for 13 proteins identified in this screen and found that they were associated with distinct groups of mRNAs, some of
them coding for functionally related proteins. We also found that overexpression of the enzyme Map1 negatively affects the
expression of experimentally defined mRNA targets. Our results suggest that many proteins may associate with mRNAs and
possibly control their fates, providing dense connections between different layers of cellular regulation.
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Introduction
Immediately when RNA is synthesized by RNA polymerases,
RNA binding proteins (RBPs) assemble on the nascent transcript
forming ribonucleoprotein (RNP) complexes, which tightly control
all of the further steps in a RNA’s life. On one hand, RBPs assist
the processing and assembly of non-coding (nc) RNAs into RNP
complexes, which mediate essential cellular functions such as
splicing and translation [1]. On the other hand, RBPs are essential
for mRNA maturation, which involves the addition of a 7-
methylguanosine cap at the 59end of mRNA-precursors, the
splicing-out of introns, editing, and the addition of a polyadenosine
tail at the 39end of the message. RBPs further guide mRNA export
and localization to specific cytoplasmic loci for translation, and
ultimately, they control the decay of (m)RNAs [2]. Notably, all
these steps are highly connected to each other and linked with
other gene regulatory layers to ensure proper expression of every
gene in a cell [3].
The availability of genomic tools now allows the systematic
identification of RNA targets for RBPs to obtain a global view of
their gene regulatory potential. One of the main approaches
include the immunopurification of RNP complexes followed by
the analysis of the associated RNAs with DNA microarrays, a
method referred to as RNA-immunopurification-microarray (RIP-
Chip). Numerous studies applying these genomic tools revealed
that many RBPs associate with distinct RNA target sets comprised
of a few up to several hundred RNAs, which are often enriched for
specific sequence/structural elements that define RBP binding
sites. The sets of bound RNAs were often related containing
mRNAs coding for functionally or cytotopically related proteins
(e.g. [4–6]; reviewed in [7–9]). These findings lead to a model that
proposes important coordinative roles for RBPs in the expression
of functionally related groups of messages, referred to as ‘RNA
regulons’ or ‘post-transcriptional operons’ [7]. Moreover, it
underscores that RBPs bind simultaneously and/or sequentially
to RNAs generating numerous RNP particles, whose dynamic
composition and combinatorial arrangement may be unique for
each mRNA expressed in a cell [8–10].
RBPs comprise 3 to 11% of the proteomes in bacteria, archaea
and eukaryotes underlining the importance of RNA regulation for
cell function [11]. In the budding yeast Saccharomyces cerevisiae, more
than 500 proteins are predicted to function as RBPs [6,10]. An
extensive bioinformatic survey, considering evolutionary conser-
vation, identified almost 100 protein motifs linked to RNA
regulation; about half of them have been classified as ‘‘enzymatic’’
domains mostly present in RNA modification enzymes and
nucleases. Another 40 motifs or so have been classified as ‘‘non-
catalytic’’ RNA-binding domains, which are often part of multi-
subunit RNP complexes [11]. Notably, RBPs often contain an
array of RNA-binding motifs (RBMs), which further increases the
specificity and affinity towards the RNA.
The vast number of protein motifs linked to RNA regulation
and the ancient origin of RNA regulation, which is possibly the
most evolutionary conserved component of a cell’s physiology,
proposes that many proteins implicated in other cellular processes
could have retained RNA-binding capacity. For instance, several
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metabolic enzymes in mammals have been shown to bind to and
regulate mRNA expression (reviewed in [12–15]). Perhaps best
characterized are the iron regulatory proteins (IRP), cytoplasmic
aconitases that regulate the translation or stability of several
messages depending on cellular iron levels [16]. Moreover, a
recent comprehensive RIP-Chip study analyzing the RNA targets
for more than 40 different RBPs and some other proteins in yeast
showed that two metabolic enzymes, for which homologs in
mammals have been reported to bind RNA, were reproducibly
associated with cellular RNAs, indicating that RNA regulation by
these proteins may be evolutionarily conserved [6]. These
observations have raised speculations about the existence of yet
largely overlooked post-transcriptional regulatory networks be-
tween intermediary metabolism and RNA regulation [12]. It
furthermore highlights the need of systematic discovery tools to
identify novel RBPs as the ‘‘universe’’ of RBPs in eukaryotes could
be well underestimated. Possibly many more proteins could have
retained or acquired the capacity to bind RNA enabling post-
transcriptional gene regulation at yet uncharacterized levels and
processes.
In this study, we set out to screen for novel and unconventional
RBPs. We therefore used protein microarrays containing 70% of
the yeast’s proteome and probed them with different sorts of RNA.
We selected almost 200 proteins that reproducibly interacted with
RNA, most of them not previously annotated to act as RNA-
binding proteins such as metabolic enzymes. We further
determined in vivo associated RNAs for 13 potential RBPs by
RIP-Chip. Most of the RBPs bound to distinct subsets of mRNA,
some of them code for functionally related proteins and thus,
possibly comprise ‘‘RNA regulons’’. Since this screen is not
saturated we expect that many more RBPs - including proteins
with dual functions - exist in eukaryotic organisms, forming a
dense and robust post-transcriptional scaffold that effectively
coordinates gene expression to ensure the integrity and stability of
a cells fate.
Results
Detection of specific RNA-protein interactions with
protein microarrays
We used functional protein microarrays to screen for proteins
that interact with RNA (Figure 1). Protein microarrays have been
previously used to identify proteins that interact with small viral
RNAs [17], but to our knowledge, there has been no screen to
detect proteins interacting with cellular RNAs. To establish the
experimental procedure, we first probed protein microarrays with
a short 36 nucleotide (nt) long RNA termed E2Bmin, which is a
fragment of the Ash1 mRNA known to specifically interact with
She2p [18]. She2 is a RBP that facilitates the localization of Ash1
mRNA and other messages to the bud-tip during cell division [19].
Among the 4,088 proteins present on the array, the strongest
signal of fluorescently labeled E2Bmin RNA was seen with She2p
(24.2 standard deviations [SD] above the mean of signal intensities
from two independent experiments; Z-scores are given in Dataset
S1). No signals were obtained with an array where proteins were
heat-denatured before probing with RNA, indicating that RNA
interactions must derive from active proteins. Besides She2, six
GTPases (Arf1, Arf3, Arl2, Ypt1, Ypt7, Ypt32; p,1029), a tRNA
guanylyltransferase (Thg1), and a single-stranded DNA-binding
protein (Rim1) also strongly and reproducibly interacted with
E2Bmin (SD.3.5 in replicates). Whether these E2Bmin binders
may be implicated in the regulation of Ash1 mRNA in vivo remains
to be elucidated. At least, these experiments show that specific
RNA-protein interactions can be detected with our experimental
set-up.
Many enzymes may interact with cellular RNAs
To screen for proteins that interact either with total RNA or
mRNAs, we basically used the same experimental set-up as
applied for the E2Bmin experiments. We probed the protein
microarrays with Cy3 labeled ‘total RNA’, which was isolated
from yeast cells grown in different carbon sources, and with Cy5
labeled mRNAs isolated from total RNA via oligo-dT columns (see
Materials and Methods). Because data was less reproducible
compared to the replicate arrays probed with E2Bmin RNA
described above, we assigned each element on the array a
percentile rank based on background subtracted signals, and
calculated median percentile ranks across the five replicates [20]
(raw data is provided in Dataset S2). Thereby, the highly ranked
proteins represent those with highest signals on the array (e.g.
She2p probed with E2Bmin RNA is ranked = 1 in the above
described experiments). The analysis of ranks instead of Z-scores
has been previously applied to analyze chromatin immunoprecip-
itation-chip data and performs well when magnitude and scale of
Figure 1. Identification of RNA-binding proteins with protein microarrays. Protein microarrays (Protoarrays) contained 4,088 different yeast
proteins (,70% of the proteome) individually spotted in duplicates onto a modified glass slide. The arrays were probed with a mixture of
fluorescently labeled RNAs. After washing, the arrays were scanned and analyzed for proteins that bound either labeled RNAs.
doi:10.1371/journal.pone.0015499.g001
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the actual signals varies between replicates [20]. If there are
features that are consistently highly ranked across multiple
replicates, the distribution of the median percentile ranks of all
features will form a bimodal curve; and the median percentile rank
at the trough of this bimodal distribution can be selected as a
conservative cut-off to define targets [20]. A histogram of the
median ranks across the five replicate protein arrays showed a
bimodal distribution, which we assumed to represent non-binders
and binders, the latter ones to be consistently highly ranked across
replicate experiments (Figure 2). We have therefore chosen the
trough of the distribution as a conservative cut-off to define
proteins that reproducibly interacted with either total RNA or
mRNAs; selecting 67 total RNA and 173 mRNA binders,
respectively (a list of the total 180 proteins selected from this
analysis is provided in Table S1). 90% of total RNA binders were
also found in the pool of mRNA binders, but most of the mRNA
binders did not strongly bind total RNA (113; 65%). These
proteins may preferentially interact with mRNAs, which are
underrepresented in the total RNA fraction. However, we wish to
note that this selection procedure was designed to go for a robust
list of potential RNA binders. It may thus not provide a
comprehensive list of all RNA-binders, and further inspection of
the data may reveal additional RNA-binders.
We categorized the selected 180 proteins that either interacted
with total RNA or mRNA based on Gene Ontologies (GO)
retrieved from the Princeton GO server. 132 out of the 180
proteins (73%) had at least one known function annotated with
GO. 28 proteins were annotated with the GO term ‘RNA-
binding’, which is therefore over-represented among the group of
all 180 selected proteins (p,1023, Figure 3; a detailed list of GO
terms is provided in Table S2). Further manual inspection of the
180 proteins revealed 18 additional proteins with RNA related
functions – adding-up to 46 proteins that act in RNA metabolism
(25% of all selected proteins; 35% of proteins with assigned
functions; marked in blue in Table S1). In contrast, DNA binding
proteins including transcription factors (TFs; 13 proteins, 7%)
were not over-represented suggesting that our assay discriminates
between DNA and RNA-binders. Moreover, only four of the 180
proteins (Bcy1p, Deg1p, Pfk26p, Yer087p) were among 208
proteins selected in a similar screen applying protein microarrays
to identify single- or double-stranded DNA binding proteins [21].
In conclusion, our list of selected proteins bears a substantial
fraction of previously known RNA-binders or proteins with RNA-
related functions, indicating that our assay likely selected proteins
that have RNA-binding properties. However, as outlined above,
our stringent cut-off is not expected to identify all of the RNA-
binders. Moreover, there are many reasons why diverse known
RBPs, which are present on the array did not give reproducible
signals across replicates. This includes inactivation of proteins on
the slide surface, mis-folding or RNA cross-hybridization in
solution, and finally, many annotated RBPs act in protein
complexes (e.g. ribosomal proteins) and thus may not specifically
interact with RNAs on their own.
Regarding the assigned functions among our list of selected
RNA-binders, we were intrigued that many of them have catalytic
functions, including oxidoreductases, hydrolases, lyases and
transferases (total 94 proteins; 52%, p,0.003) (Figure 3, Table
S2). Whereas 17 of these enzymes have been previously linked to
RNA related processes, the remaining ones act in unrelated
processes such as fatty acid metabolism (p,0.007) or lipid
oxidation (p,0.008). Moreover, 25 of these enzymes can be
mapped to the yeast metabolic network [22], which are therefore
significantly overrepresented compared to all of the metabolic
enzymes in this network present on the protein microarray (397
proteins, p,0.016). In agreement with this bias for enzymes, most
of the herein identified potential RBPs are cytoplasmic (141
proteins, p,1026), membrane-associated (p,0.003), and some of
them located to peroxisomes (p,261025)(Figure 3). These results
indicate that many cytoplasmic enzymes could interact with RNA.
In principle, this could provide opportunities to directly connect
intermediary metabolism with posttranscriptional gene regulation.
We further analyzed our experimentally defined set of 180
RBPs for the occurrence of protein domains annotated by the
Pfam database [23]. 4,049 proteins in S. cerevisiae were annotated
Figure 2. Selection of mRNA and total RNA-binding proteins.
(A) Distribution of ranked median signal intensities resulting from
protein microarrays probed with mRNAs. The trough at 0.9 was taken as
cut-off and all proteins with greater ranks were selected as mRNA
binders. (B) Distribution of ranked median signal intensities resulting
from arrays probed with total RNA. The trough at 0.95 was taken as cut-
off and all proteins with greater ranks were considered as total RNA
binders. (C) Venn Diagram representing overlap between proteins
binding to total RNA and mRNAs.
doi:10.1371/journal.pone.0015499.g002
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with 6,119 domains in Pfam, and we analyzed whether some of
these domains were over-represented among the 150 proteins (out
of 180) that contained at least one Pfam domain (Pfam domains
are annotated in Table S1). As expected, most prevalent were
known RNA-binding domains such as the K homology (KH_1)
domain, the RNA recognition motif (RRM_1) and a subtype of
the zinc finger motif, zf-CCHC, which were all significantly
enriched (Table 1). Interestingly, several domains were enriched
that have not been previously related to RNA function (p,1023,
hypergeometric) and occur in proteins devoid of other known
RNA-binding motifs. This includes the ubiquitin motif or the
weakly conserved repeat module PC_rep, which are found in
several proteins involved in protein degradation control [24]. It
also includes the WW motif and the TPR_1 (tetratricopeptide
repeat), which mediate protein-protein interactions and the
assembly of multiprotein complexes [25], and several enzymatic
domains contained in metabolic enzymes. Whether any of these
domains directly or indirectly mediate RNA-binding has yet to be
investigated, but their significant overrepresentation makes them
prime candidates for further analysis.
Potential RBPs come from different expression regimes
We next asked how the expression of our selected RNA-binders
varies across different growth conditions to see whether our
selection is biased to any kind of expression characteristics. We
therefore compiled a large collection of microarray data available
for a wide range of experimental conditions for S. cerevisiae from the
M3D database [26] (experimental conditions are indicated in the
Table S3). Because this data is available in Robust MultiArray
(RMA) normalized format [27], it enables direct comparison of
expression levels (see Materials and Methods). Expression profiles
could be obtained for 164 of the 180 RBPs identified in this study,
and we performed K-means clustering with 10 groups to identify
subsets of genes that exhibited similar expression patterns. This
analysis revealed that the genes followed very heterogeneous
expression patterns; genes clustered into different expression
regimes namely ubiquitously highly expressed, ubiquitously poorly
expressed and specific to conditions (a heatmap cluster of this
analysis is shown in the Figure S1).
We further compared the expression levels of the potential RBPs
identified in this study with previously annotated RBPs (seeMaterial
and Methods). We found no general difference (p,0.64, Wilcoxon
test). However, our herein identified RBPs are generally higher
expressed than non-RBPs (p,261026, Wilcoxon test); an observa-
tion that has been made previously for conventional RBPs as well
[28]. We therefore speculate that in particular the highly expressed
unconventional RBPs may give good leads for future experiments as
they have the potential to control many RNA targets [28].
Figure 3. Significantly shared GO terms among mRNA binders. The 173 m RNA binders were searched for significantly enriched GO terms as
compared to all the 4,088 proteins present on the protein microarray. Bar diagrams indicate relative amount of genes of the respective GO term
among all proteins on the array or among the selected mRNA binders, respectively.
doi:10.1371/journal.pone.0015499.g003
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Selected novel RBPs associate with distinct sets of
mRNAs
To examine whether some novel potential RBPs in our selected
list of RNA-binders associate with RNA in vivo, we purified
endogenously expressed tandem-affinity purification (TAP)-tagged
proteins from cells grown in rich media, and identified co-
purifying RNAs with yeast DNA oligo arrays. From our list of 180
RBPs, we selected 13 proteins that are expressed at different levels,
and for which respective mRNA expression patterns are different
across a variety of conditions, providing a representative sample of
differentially expressed putative RBPs (marked in Figure S1).
Besides a transcriptional regulator (Lap3p) and a co-chaperone
(Sti1p), we selected eleven proteins with catalytic activities (Dfr1p,
Gre3p, Map1p, Mdh1p, Mdh3p, Meu1p, Pfk2p, Phr1p, Pot1p,
Pre10p, Ymr1p), some of them acting in intermediary metabolism,
reflecting the fact that many candidate RBPs are enzymes. Seven
of the proteins are cytoplasmic, two are peroxisomal, and one
representative each are from the nuclear, mitochondrial, ribo-
somal and proteasome compartment.
We performed three independent affinity isolations with each of
the 13 potential RBPs and five independent mock isolations with
untagged control cells ( =mock isolates). To identify RNA that
were significantly associated with the proteins we selected those
features that were on average at least 3-fold enriched in the affinity
isolates compared to the mock controls with a p-value of less than
0.01 (see Materials and Methods). This analysis revealed that all
proteins were associated with unique sets, comprised of a few to
dozens of different RNAs (Figure 4; raw data from RIP-Chip
experiments and a list of selected features is given in the Dataset
S3). Notably, the proteins were almost entirely associated with
mRNAs, excluding highly expressed ncRNAs such as rRNAs,
tRNAs and snoRNAs. This indicates that these candidate RBPs
primarily target mRNAs for potential gene expression control. It
also substantiates the specificity of our assays as there is no
apparent bias for selection of highly expressed ncRNAs. We also
found no correlation between the expression level of these proteins
[29] and the number of selected targets (Pearson correlation
r=0.04), further substantiating that the observed associations are
selective and not merely driven by expression.
Four of the 13 proteins (30%) were associated with their own
mRNA (Pfk2, Pre2, Map1, Meu1). Binding to the own mRNA
offers the possibility for auto-regulation through the formation of
positive or negative feedback loops [30]. This fraction is therefore
similar to previous finding with canonical RBPs, where 18 of 46
RBPs (40%) were associated with their own RNA [6]. Remark-
ably, this fraction is considerably larger compared to TFs, where
10% bound to their own promoter sequences in a global TF-
binding site analysis for 106 TFs [30].
Because many RBPs bind to mRNAs coding for functionally
related proteins, we searched for common themes among the
messages that were associated with the 13 proteins. For six
proteins (Map1, Mdh3, Pot1, Pre10, Sti1, and Ymr1) we found
Table 1. Pfam domains enriched in the list of putative RBPs.
Domain Occurrence (RBPs) Occurence (Genome) Occurrence (Protoarray) P-value (Hypergeometric)
KH_1 10 18 16 5.44E-09
zf-CCHC 8 23 15 1.06E-06
RRM_1 12 78 41 4.75E-06
ubiquitin 6 15 15 0.00018
PC_rep 4 7 7 0.00048
TPR_1 6 27 19 0.00077
WW 4 8 8 0.00089
adh_short 4 13 9 0.0015
S1 3 6 5 0.0023
TYA 5 81 18 0.0038
Ldh_1_C 2 3 2 0.0041
TBP 2 2 2 0.0041
cNMP_binding 2 5 2 0.0041
Acyl_CoA_thio 2 2 2 0.0041
Ldh_1_N 2 3 2 0.0041
PseudoU_synth_1 2 6 2 0.0041
doi:10.1371/journal.pone.0015499.t001
Figure 4. Selected novel RNA-binding proteins bind to distinct
sets of mRNAs. (A) Heat map of mRNAs associated with indicated
proteins. The color code (orange-blue) indicates the fold-change (log2
ratio scale) of the respective feature in the affinity isolation compared to
mock control microarray data. The number of mRNA targest for each
protein is indicated next to the name of the protein. A star (*) denotes
association with own mRNA. ‘GO’ indicates that GO terms are
significantly enriched among targets (see Table 2).
doi:10.1371/journal.pone.0015499.g004
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significantly enriched GO groups among associated messages,
offering the potential to coordinate expression of functionally
related groups of messages or ‘RNA regulons’ (Table 2; a more
comprehensive list of GO terms is provided in the Table S4).
Noteworthy, proteins associated with only a few messages may be
less prone for this analysis as the number of the associated mRNAs
might be too small to achieve statistically sound data. Although
every protein assembled with unique GO terms (e.g. Sti1p bound
mRNAs code preferentially for proteins acting in telomere
maintenance and DNA recombination), some of the enriched
GO terms appeared with more than one protein. For instance,
messages associated with Map1p, Pot1p, and Ymr1p are
commonly related to translation. However, the particular
messages that added to this term were mostly different and only
one message (Rps9b) was shared among the targets for the three
proteins. Likewise, three proteins (Map1, Mdh3, Sti1) were
preferentially associated with messages coding for proteins
annotated with pyrophosphatase activity. Among the many targets
for these proteins, only eight mRNA targets are shared, which do
not link to pyrophosphatase activity (two pyruvate decarboxylases
[Pdc1, Pdc5] were commonly enriched; p,261024). Therefore, it
appears that although some GO terms were enriched with more
than one of the proteins, it is not because these proteins bound to a
common set of messages that connects to one particular GO term,
but rather that they were associated with different messages that
belong to the same functional class.
Map1p negatively affects gene expression of mRNA
targets
To investigate how one of the selected candidate enzymes could
affect gene expression of targets, we measured the relative changes
of mRNA levels of cells overexpressing MAP1 compared to control
cells with DNA microarrays. Map1p is a methionine aminopepti-
dase (MetAP) that catalyzes the co-translational removal of N-
terminal methionine from nascent polypeptides, and it is function-
ally redundant with Map2p [31,32]. Notably, Map1p contains two
zinc-finger motifs, one CCCC-type and the other of the CCHH-
type [33], which occur in DNA-binding proteins and in some RBPs
[34] – however these domains were not thought to provide selective
RNA-binding but rather to confer interaction of Map1p with the
ribosome [35]. Yeast cells bearing a plasmid with MAP1 under the
control of galactose inducible promoter, and control cells containing
an empty plasmid, were grown to mid-log phase and expression was
induced with 2% galactose for 1.5 hours. Noteworthy, inducible
short-time overexpression of RBPs could be beneficial to measure
direct effects of proteins on gene expression by minimizing
secondary effects that may raise after prolonged alterations of
expression levels (Scherrer et al., submitted). We obtained mRNA
expression profiles for 6,851 features representing 5,889 yeast genes
(raw data is provided in Dataset S4).MAP1 expression was increased
4.2-fold being the most changed mRNA of all analyzed features.
The relative expressions levels of Map1p target mRNAs were very
slightly (mean fold change= 0.925) but significantly decreased
compared to all non-targets (p,1025, Mann-Whitney U test)
(Figure 5). Of note, only 44 genes changed at least 1.5 fold with
p,0.05 (one sample t-test); and seven Map1p targets were
overrepresented among the 36 down-regulated messages
(p=761025, Fisher’s exact test). The same analysis with microarray
data obtained from cells overexpressing GIS2 (another ZnF protein
among the selected RNA-binders) did not reveal reduced expression
ofMap1p targets (TS and APG, unpublished results), indicating that
the observed shift in the distribution of Map1p targets was not a
general effect due to protein overexpression. In conclusion, these
results suggest that Map1p could negatively affect mRNA
expression of selected mRNA targets.
Discussion
Protein microarrays have been applied to detect protein-
protein, protein-lipid, protein-DNA and protein-viral RNA
interactions [17,21,36,37]. Here, we describe the use of protein
microarrays for the detection of protein-RNA interactions. We
identified dozens of potentially ‘‘novel’’ RBPs that either
interacted with mRNA or total RNA on protein microarrays.
Strikingly, among these were many enzymes with well-established
cellular functions. For some of them, we have shown significant
association with functionally related messages, possibly allowing
coordination of the expression of ‘RNA regulons’ as seen for bona
fide RBPs. This was further initially demonstrated for Map1p, for
which we observed subtle coordinated down-regulation of target
mRNAs upon MAP1 overexpression, indicating that Map1p
preferentially negatively affects gene expression of target messages.
This study therefore expands our understanding of post-transcrip-
tional gene networks suggesting regulatory functions to a variety of
proteins not connected to gene expression regulation so far.
Table 2. Selected list of GO terms enriched among mRNA targets.
Protein Category GO term (p-value)
Map1 Process translation elongation (1027), small molecule metabolic process (1025)
Function catalytic activity (10211), pyrophosphatase activity (261027)
Compartment plasma membrane enriched fraction (10210), ribosome (461026)
Pre10 Function hydrolase activity (0.007)
Sti1 Process telomere maintenance via recombination (561025)
Function helicase activity (10214), pyrophosphatase activity (10210)
Ymr1 Process translation (3610211)
Function structural constituent of ribosome (10210)
Compartment ribosome (6610214)
Mdh3 Function nucleoside-triphosphatase activity (1023), helicase activity (261023)
Pot1 Process translation (8610210)
Function structural constituent of ribosome (8610212)
doi:10.1371/journal.pone.0015499.t002
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Our observations that many proteins with enzymatic activities
bind to RNAs and potentially participate in RNA regulation are
reminiscent to previous observations stating RNA-binding func-
tions for several mammalian enzymes (reviewed in [12,13]). These
mammalian enzymes revealed a striking common denominator –
they catalyze reactions that often involve mono- or dinucleotides
as substrates or co-factors [14]. Similarly, we found that a large
fraction (41 proteins) of the ‘‘novel’’ RBPs with assigned catalytic
activities (total 95 proteins) require nucleotide related cofactors/
substrates (Table S1): 14 proteins require ATP/AMP as substrate
(e.g. kinases), 13 need nicotinamide adenine dinucleotides (NAD)
or its 5-phosphate derivate (NADP) as a cofactor, seven employ
Coenzyme-A (CoA) found in many enzymes acting in the sterol/
fatty acid metabolism, and nine use others such as GTP/GMP or
S-adenosyl-methionine. In this regard, the protein binding site for
NAD or NADP has been postulated to have occasionally evolved
to a binding surface for polyribonucleotides in some mammalian
enzymes (e.g. thymidylate synthase (TS) and dihydrofolate
reductase (DHFR), as well as glyceraldehyde-3-phosphate, isocit-
rate, and lactate dehydrogenases) [14]. We tested four (Gre3, Dfr1,
Mdh1, Mdh3) NAD binding proteins for association with cellular
RNA with RIP-Chip and found that all of them were reproducibly
associated with mRNAs, proposing that their NAD binding sites
could also have evolved to conduct some RNA regulatory
functions. Interestingly, the strong prevalence for nucleotide
binding sites among the putatively novel RBPs is also in analogy
to recent observations suggesting the existence of transcription
regulators that are metabolic enzymes [38]. This raises the
possibility that both TFs as well as RBPs might function as direct
sensors of the metabolic state of the cell suggesting novel circuits
for gene regulation. In this scenario, the binding of metabolic
cofactors in the reduced or oxidized form (e.g. NAD/NADH+)
could differentially regulate the activity of responding RBPs, either
through impacting RNA-binding or modulating interaction with
other RNP components. Therefore, careful evaluation of the
redox state and of the substrate availability will be of further need
to decipher the molecular roles of enzymatic RBPs. In addition,
modulation of RNA-binding function may result from direct
competition between RNA and substrates/cofactors as seen with
mammalian IRPs, TS and DHFR [15,16]. In that case, RNA
binding can only occur when substrates are limiting and/or
enzymes are in excess and thus, this could possibly contribute to
some of the weaker associations seen between RNA and some of
the enzyme-related RBPs in our RIP-Chip experiments.
Our screen also proposes RNA binding properties for enzymes
that act independently of nucleotides or other cofactors such as
peptidases and phosphatases (e.g. Map1, Ymr1). Moreover, our
analysis for the enrichment of Pfam domains among our selection
of RNA-binders revealed several unexpected domains to be
associated with proteins identified in our screen, namely protein-
protein interaction domains such as the tetratricopeptide repeat
superfamily, which includes the PC_rep and TPR1_domains [23].
We confirmed association of a substantial set of mRNAs with one
of the representatives of this family, Sti1p, which contains four
TPR1 domains. Although we do not know whether the measured
interactions occur directly, it is feasible that some TPR domains
could have acquired (or lost) RNA binding functions during
evolution: The TPR motif consists of three to 16 tandem-repeats
of 35 amino acids that fold into a helix-turn-helix structure and
hence, the motif is thought to be closely related to pentatricopep-
tide repeats (PPR) [39]. The PPR domains rapidly expanded in
plants (100–500 genes) where proteins bearing these domains have
well established functions in RNA binding, making it reasonable to
speculate that some closely related TPR motifs might also have
RNA-binding properties.
Nevertheless, the RNA-binding site may also be distinct from
the enzymatic site. Diverse examples for shuffling of enzymatic
domains next to RNA-binding domains are known such as
adenosine deaminases acting on RNA or RNA helicases [40].
Some proteins also retained enzymatic functions in metabolism
such as Rib2p in yeast [41]. We analyzed the RNA regulatory
potential for Map1p (a methionine aminopeptidase), for which the
catalytic domain (peptidase) may be well separated from the RNA-
binding sites. The protein contains two Zn-finger domains, which
are essential for the normal processing function of MetAP in vivo
[33] and were thought to provide interaction with the ribosome
[35]. However, Zn-finger domains have been widely seen to
mediate protein-DNA or protein-RNA interactions [34] and
hence, they may act as RNA-binding motifs in Map1p as well.
Howsoever, based on your results it appears that Map1p is a dual
function enzyme that can negatively affect the expression of some
mRNAs targets, including messages coding for proteins that act in
translation – in particular translational elongation – and which are
therefore in the same process as Map1p.
Several mammalian metabolic enzymes are thought to control
the translation or stability of their own mRNAs [13]. For instance,
Figure 5. Gene expression profiling of yeast cells overexpress-
ing MAP1. Distribution of average Cy5/Cy3 fluorescence ratios from
three microarray hybridizations comparing RNA levels of MAP1 over-
expressing yeast cells with control cells. In the upper panel, the fraction
of transcripts indicated on the y-axis refers to the cumulative fraction of
sequences on the microarray; log2 ratios are plotted on the x-axis. The
lower panel shows a histogram depicting the fraction of transcripts (y-
axis) that are clustred within bins of 0.1 log2 ratios (x-axis). The red line
delineates the distribution of Map1p RNA targets defined from affinity
purifications. The blue line represents non-targets.
doi:10.1371/journal.pone.0015499.g005
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TS binds with high affinity to its own 59-UTR near the initiator
AUG codon and represses translation [15]. Thereby, mRNA
binding sites in TS overlap with the binding sites for its substrates,
methylenetetrahydrofolate and dUMP and therefore, mRNA and
substrate are in direct competition. Likewise, DHFR, a second
enzyme in the thymidylate synthesis pathway also binds to its own
mRNA, which can be competed by the substrate (folate)
antagonist methotrexate [13,15]. Four proteins, for which mRNA
targets were identified with RIP-Chip bound to their own
mRNAs, offering the possibility for auto-regulation (Figure 4).
Among these was also Pfk2p, which is the b-subunit of the hetero-
octameric phosphofructokinase (PFK) involved in glycolysis.
Noteworthy, the specific associations of Pfk2p with its own
message are independent of the PFK complex, as neither our
protein array nor the RIP-Chip analysis revealed significant
associations of RNAs with the other subunit of this complex,
termed Pfk1p (TS and APG, unpublished results). Since glycolysis
is crucial for cell physiology, the activities of enzymes acting in this
pathway must be tightly controlled, which is mainly thought being
accomplished by transcription and/or the regulation of protein
synthesis or degradation [42]. The binding of Pfk2p to its own
message could provide an additional layer of expression regulation
by controlling the translation, localization or the stability of the
message. Such post-transcriptional feedback regulation could add
a sensitive mechanism to adapt PFK levels to changing
environmental conditions. We wish to note that self-controlling
functions among RBPs generally appear to occur more often than
among transcription factors, as about 30–40% of RBPs are
associated with their own messages compared to 10% of
transcription factors that bind to their own promoters [30]. We
speculate that such auto-regulation might be beneficial for RBPs in
some specific circumstances to control their expression in a
temporal and spatial context with respect to other RBPs, and as a
means to fine-tune their levels in the cell for appropriate
combinatorial interplay.
In conclusion, various instances of enzymes that also act in
RNA-metabolism have been previously reported. Our findings put
these specific examples into a more general context indicating that
RNA regulation by enzymes may be far more common than
previously anticipated. A good fraction of (metabolic) enzymes
may therefore have a ‘‘moonlighting’’ role in regulating RNA
metabolism, which could allow establishing various direct
connections between metabolic status and post-transcriptional
gene regulation [12]. Future studies on the regulation of mRNA
targets by both enzyme-related and conventional RBPs in yeast
and other species will help to further shape the RNA-protein
interaction network and its regulatory potential and plasticity, and
to further establish novel connections between different layers of
cellular control.
Materials and Methods
Plasmids, strains and media
TAP-tagged strains [29] and the isogenic wild-type strain
BY4741 (MATa his3D1 leu2D0 met15D0 ura3D0), as well as
plasmid pBG1805-Map1 [44] were obtained from Open Biosys-
tems. Yeast cells were grown in yeast-peptone-dextrose medium
(YPD; 1% yeast extract, 2% bacto-tryptone, 2% glucose) or in
synthetic complete medium (SC) [45]. YPGal and YPG are
identical to YPD except that they contain 2% galactose or 3%
glycerol, respectively, instead of glucose; and SG and SR are
identical to SC but contain 2% galactose or 2% raffinose,
respectively, instead of glucose. SC-Ura corresponds to SC lacking
uracil.
RNA preparation and labeling
20 pmol of forward and reverse complementary oligonucleo-
tides encoding the E2Bmin sequence [18] and the T7 RNA
polymerase promotor were incubated for one minute at 95uC in
20 ml of water and annealed by cooling down the reaction slowly
to room temperature (RT). E2Bmin RNA was synthesized by
transcription of annealed DNA templates with T7 RNA
polymerase (Promega) for two hours at 37uC. The reactions were
treated with DNase I (Roche), and RNA was extracted with
phenol/chloroform and precipitated with ethanol. The integrity of
the RNA fragment was controlled on a 15% polyacrylamide gel
containing 8 M urea. Total RNA was isolated from yeast cells by
hot phenol extraction [46]. Total RNA was isolated from cells
grown either in YPD, SCGal, SD, YPGal, YPG and combined at
the ratio (w/w) 2:2:1:1:1. Messenger RNA was isolated from
pooled total RNA with the Oligotex mRNA Mini Kit (Qiagen)
according to the manufacturer’s protocol. Concentration of RNA
was generally assessed by UV-spectrometry with a Nanodrop
device (Witeg).
RNA was fluorescently labeled with either Cy3 or Cy5 using the
MICROMAX ASAP RNA labeling Kit (Perkin Elmer Cat#
MPS544) according to the manufacturer’s protocol. Labeled RNA
was purified with the RNeasy Micro kit (Qiagen) to remove
unincorporated dyes and immediately used for array analysis.
Protein microarrays and data analysis
We used commercially available protein microarrays containing
duplicate probes of 4,088 yeast proteins and additional control
proteins spotted on a modified glass slide (ProtoArrayTM Yeast
Proteome Microarray mg v.1.0; Invitrogen Cat# PA012106;
http://www.invitrogen.com). The frozen arrays were thawed at
4uC for 15 min and blocked for 2 hours at 4uC in phosphate-
buffered-saline pH 7.4 (PBS; Invitrogen) supplemented with 1%
nuclease/protease-free BSA (Equitech-Bio), 1 mM DTT, 50 mg/
ml E. coli tRNA (Roche), and 50 mg/ml heparin. The arrays were
dried by centrifugation at 300 g for 1 min at 4uC and immediately
probed with fluorescently labeled RNAs. Therefore, Cy3 labeled
total RNA (5–10 mg) were combined with either Cy5 labeled
mRNAs ( = poly(A)+ RNA; 2 mg) or E2Bmin RNA (1.5 mg) and
mixed in 60 ml of RNA-binding buffer (RBB, 20 mM Tris-HCl
pH 7.9, 75 mM NaCl, 2 mM MgCl2, 5% glycerol, 0.05% Triton-
X100, 1% BSA, 1 mM DTT, 0.2 mg/ml E. coli tRNA, 0.02 mg/
ml heparin) supplemented with 6 U of RNaseOUT (Invitrogen,
Cat# 10777-019) and applied on the protein microarray, which
was covered with a lifterslip (22660 mm; Erie Scientific). The
arrays were put into a sealed hybridization chamber to prevent
drying-out, and incubated for 90 min at room temperature in the
dark. The slides were washed twice for 10 min at 4uC with 25 ml
of RBB buffer supplemented with 10 U/ml RNaseOUT, and
twice with 16RBB buffer lacking tRNA. The arrays were dried by
centrifugation at 300 g for 5 min and immediately scanned with
an Axon Scanner 4200 (Molecular Devices). Data was collected
with GenePix Pro 5.1 (Molecular Devices) and imported into
Acuity 4.0, which averages data for duplicated spots (Molecular
Devices). For data analysis, we removed features representing non-
yeast control proteins (e.g. GST) and spots with irregular shapes
(FLAG.=0). Protein microarray raw data have been deposited at
ArrayExpress via http://www.ebi.ac.uk/miamexpress/(accession
number: E-MEXP-2897; see below).
To select proteins that bind E2Bmin RNA, we retrieved
median signal intensities of background subtracted signals for the
red channel (Cy5) probed with E2Bmin RNA. Proteins, for which
the signal intensities were at least 3.5 standard deviations (Z
score.3.5) above the median of all averaged signals from
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replicate arrays, were considered as RNA binders (raw data is
given in the Dataset S1). To select proteins that interact with total
RNA or mRNAs, we retrieved background subtracted median
signal intensities of both channels from five replicate arrays, and
calculated percentile ranks from 0 to 1 for each channel and array
(raw data is given in Dataset S2). The distribution of the median
percentile ranks across array replicates was plotted as a histogram
and the trough of the bimodal distribution was taken as a
conservative cut-off to select proteins that consistently interacted
with RNAs (0.90 for mRNA, and at 0.95 for total RNA)
(Figure 2).
RNA affinity isolations
Affinity purification of TAP-tagged proteins was carried out as
described previously [4,6], except that yeast cells were broken
mechanically with glass beads in a Tissue Lyser (Qiagen) for
12 min at 300 Hz and 4uC. RNAs from the extract (input) and
from the affinity isolates were purified with the RNeasy Mini or
Micro Kit (Qiagen), respectively.
MAP1 overexpression
100 ml of BY4741 cells bearing plasmid pBG1805-Map1 or the
empty plasmid pBG1805 ( = control) were grown in SR-Ura media
at 30uC to an OD600 of 0.45–0.5 and expression was induced with
2% galactose for 1.5 hours. Cells were generally harvested by
centrifugation and washed twice with 800 ml of ice-cold sterile
water. RNA was isolated by hot-phenol extraction for microarray
analysis as described above [46].
DNA microarrays and data analysis
70-mer oligo arrays representing features for all annotated
nuclear yeast genes (including all ORFs and ncRNAs, introns and
some intergenic regions), the mitochondrial genome and various
control spots were produced at the Center for Integrative
Genomics, University of Lausanne. Arrays were processed and
hybridized with fluorescently labeled cDNAs as described
previously [47]. For RIP-Chip experiments, 5 mg of total RNA
isolated from the extract (input) and up to 50% (,500 ng) of the
affinity purified RNA were reverse transcribed in the presence of
5-(3-aminoallyl)-dUTP and natural dNTPs with a mixture of
randome nonamer and dT(20)V primers, and cDNAs were
covalently linked to Cy3 and Cy5 NHS-monoesters (GE
HealthSciences Cat# RPN5661), respectively, and competitively
hybridized on yeast oligo arrays at 42uC for 14 hours in
formamide-based hybridization buffer. Gene expression changes
upon MAP1 overexpression were obtained by comparative
microarray analysis of Cy3 labeled cDNAs derived from cells
expressing the empty vector (pBG1805) and of Cy5 labeled
cDNAs from MAP1 (pBG1805-Map1) expressing cells. Micro-
arrays were scanned with an Axon Scanner 4200A (Molecular
Devices) and analyzed with GenePix Pro 5.1 (Molecular Devices).
Arrays were deposited and computer normalized at the Stanford
Microarray Database [48]. All DNA microarray data are available
at the Stanford Microarray Database (SMD) or at the Gene
Expression Omnibus at www.ncbi.nlm.nih.gov/geo (accession nos.
GSE21850 and GSE21864).
Log2 median ratios from three independent RBP affinity
isolations and five mock control isolations were retrieved from
SMD and exported into Microsoft Excel after filtering for signal
over background .1.8 in the channel measuring total
RNA derived from the extract. We used the web interface for
Cyber-T (http://cybert.microarray.ics.uci.edu/) to employ sta-
tistical analyses based on regularized t-tests that use a Bayesian
estimate of the variance among gene measurements within an
experiment [49]. Features, for which data was obtained in more
than 60% of the arrays and that were on average 3-fold enriched
with a p-value of less than 0.01 in protein affinity isolates
compared to mock controls were considered as potential RNA
targets (Dataset S3). For MAP1 overexpression profiling, log2
median ratios from three biological replicates were filtered for
regression correlation ,0.6 and signal over background .2.0 in
both channels (Dataset S4).
Microarray data files
Protein microarray raw data are available at the ArrayExpress
database at http://www.ebi.ac.uk/microarray-as/ae/(acession no.
E-MEXP-2897). DNA microarray raw data are available at the
Stanford Microarray Database (SMD) or at the Gene Expression
Omnibus at www.ncbi.nlm.nih.gov/geo (accession nos. GSE21850
and GSE21864). Microarray data is compliant with MIAME
protocol.
Databases and bioinformatics
Significantly shared GO terms among the selected proteins from
the Protoarray screen were identified with the Generic Gene
Ontology (GO) Term Finder at the Lewis-Sigler Institute at
Princeton University (release 27-Jan-2009; http://go.princeton.
edu/cgi-bin/GOTermFinder, [50]) based on annotations in the
Saccharomyces cerevisiae Genome Database (SGD). Commonly
enriched GO terms among mRNAs associated with selected
proteins were retrieved with the GO Term Finder that uses a
hypergeometric distribution with Multiple Hypothesis Correction
to calculate p-values (SGD; www.yeastgenome.org). Thereby, we
used 6,336 features representing ORF probes for which micro-
array data was obtained as the background gene set, and only
terms with p,0.01 (Bonferroni corrected) were considered.
Domain annotations for all S. cerevisiae proteins were retrieved
from the Pfam database (Pfam 24.0) at http://pfam.sanger.ac.uk/
[23]. Significance for enrichment of Pfam domains among RBPs
was calculated based on domain content on the Protoarray by
using hypergeometric distribution available from the R package
for statistical computing.
Expression analysis of selected RNA-binders across
conditions
247 microarray datasets (Affymetrix data) in the form of Robust
Multi Array (RMA) normalized profiles were retrieved from the
M3D database [26] (conditions are indicated in Table S3). K-
means clustering was performed across conditions with the
Euclidean distance metric and added into 10 groups. To compare
the expression level of novel RBPs against previously documented
RBPs [6] and non-RBPs, the latter defined as those which do not
encode for documented or novel RBPs, we calculated the median
expression level of a gene across the conditions in the M3D dataset
and compared the populations using Wilcoxon rank-sum test or
Mann-Whitney U test available in the R statistical package [28].
Supporting Information
Figure S1 Heatmap of expression profiles for 164
potential RBPs across 247 conditions. RBPs are clustered
with k-means (10 groups) by employing the Euclidean distance as
the distance metric to group similarly expressed genes across
conditions (see Materials and Methods). Red means high
expression and green reflects low expression after the microarray
data has been RMA normalized across all experiments. General
expression characteristics and the 13 proteins selected for RIP-
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chip experiments are marked next to the gene cluster. The
experimental conditions are described in the Table S3. (TIF)
Table S1 List of 180 selected proteins interacting with
total RNA or mRNA on protein microarrays. Columns
indicate the following (from left to right): YORF, gene name,
GO annotations, protein interacted with respective RNA on
protein microarrays, classified as metabolic enzyme, number of
proteins per cell [28], Pfam domains. Proteins used for affinity
isolations are labeled in red. Proteins interacting with mRNAs
are marked with red-filled boxes; proteins selected with total
RNA are in green; yellow are the ones that interacted with both
types ofRNA.     (XLS)
Table S2 Significantly enriched GO terms among
proteins interacting with total RNA or mRNA.
Table S3 List of conditions for microarray data re-
trieved from the M3D database.
Table S4 A selection of significantly enriched GO terms
among messages associated with proteins. Terms that
belong to the GO category ‘Process’ are written in black; GO
terms for ‘Function’ are in red, and the ones for ‘Compartment’
are in blue. (XLS)
Dataset S1 Raw data for protein arrays probed with
E2Bmin RNA. Columns indicate the following (from left to
right): YORF, gene name, Z-scores of two protein arrays probed
with E2Bmin, mean of Z-scores, Z-scores of heat-treated protein
microarray, GO process, function, S. cerevisiae Genome Database
Identifier. (XLS)
Dataset S2 Raw data of protein arrays probed with total
RNA and mRNA. Background substracted median fluorescent
signals are shown for both channel, and the percentile ranks and
selected proteins preferentially interacting either with mRNA or
total RNA are also shown. A key describes different worksheets. 
Dataset S3 RIP-Chip data for 13 potential RBPs.
Features/ORFs that were at least 3-fold enriched compared to
mock isolates with p,0.01 are indicated in a separate worksheets.
Therein, fold changes (log ratios) are in black,2 p-values are shown
in red. (XLS)
Dataset S4 Microarray raw data of MAP1 overexpress-
ing compared to control cells. Columns indicate the following
(from left to right): Spot ID (SMD); YORF; Gene name; log ratio
2
for triplicate experiments (MAP1/control); average log ratio;
2
average fold-change; standard deviation; p-value; Map1 target
(1 = target, 0 = non-target). (XLS)
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